FIRST WAVE BIOPHARMA (FWBI)

US33749P4081 - Common Stock

2.74  +0.01 (+0.37%)

After market: 2.82 +0.08 (+2.92%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to FWBI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 36.72. This target is 1240.15% above the current price.
FWBI was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FWBI.
In the previous month the buy percentage consensus was at a similar level.
FWBI was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 2.7436.3636.7236.7237.80 - 1,227.01% 1,240.15% 1,240.15% 1,279.56%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-03-25 HC Wainwright & Co. Reiterate Neutral
2024-03-15 Roth MKM Maintains Buy -> Buy
2024-01-03 Roth MKM Maintains Buy -> Buy
2023-09-19 Roth MKM Reiterate Buy -> Buy
2023-07-14 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-06-29 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-26 HC Wainwright & Co. Reiterate Buy
2023-04-05 HC Wainwright & Co. Maintains Buy
2023-03-09 HC Wainwright & Co. Reiterate Buy
2023-02-03 HC Wainwright & Co. Reiterate Buy
2023-01-31 HC Wainwright & Co. Reiterate Buy
2023-01-26 HC Wainwright & Co. Reiterate Buy
2022-12-02 HC Wainwright & Co. Maintains Buy
2022-05-26 Roth Capital Maintains Buy
2021-12-07 Maxim Group Downgrade Buy -> Hold